It has been determined that the BRAF gene is an oncogene of the RAF/MEK/ERK pathway in non-small cell lung cancer (NSCLC), leading to abnormal activation of the pathway [55, 56]. This evidence concerns the gene BRAF and non-small cell lung carcinoma.